Libya vs South Sudan: Access to anti-retroviral drugs, female
Libya
52.0%
in 2023
South Sudan
51.0%
in 2024
Libya rank
116th
South Sudan rank
118th
Access to anti-retroviral drugs, female over time
- Libya
- South Sudan
How they compare
Libya currently reports 52.0% against 51.0% in South Sudan, a difference of 1.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 116th and South Sudan ranks 118th of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.2% | 0.1% | 9.1% | Libya |
| 2010s | 41.6% | 12.1% | 29.5% | Libya |
| 2020s | 50.2% | 38.0% | 12.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Libya or South Sudan?
- Libya, at 52.0% against 51.0% in South Sudan as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Libya and South Sudan?
- 1.0%, with Libya ahead.
- How many years of comparable data are there for Libya and South Sudan?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and South Sudan rank globally for access to anti-retroviral drugs, female?
- Libya ranks 116th and South Sudan ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.